Aptose Biosciences, Inc. Wt, $0.25, Due Exp 11/25/2029
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Aptose Biosciences, Inc. Wt, $0.25, Due Exp 11/25/2029 in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was Gleason Group, Inc. ($0).
- Company
- Aptose Biosciences, Inc. Wt, $0.25, Due Exp 11/25/2029
- CUSIP
- 038997391
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Gleason Group, Inc. | 0.00% | No change | 62,500 | $0 |
"% of holder's portfolio" is APTOSE BIOSCIENCES, INC. WT, $0.25, DUE EXP 11/25/2029's weight in each manager's 13F, not the share of Aptose Biosciences, Inc. Wt, $0.25, Due Exp 11/25/2029 the manager owns.